STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

XENE XENON PHARMACEUTICALS INCORPORATED StockScouter® Report

3

StockScouter® Score

XENON PHARMACEUTICALS INCORPORATED, a small cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a small company like XENE

 

Concerns

  • The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
  • One or more analysts has modestly decreased quarterly earnings estimates for XENE. Negative
  • Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 60% done.
Progress: 40% done.
Low
High

Core Model Grades

C
C
F
D

Previous Ratings

3
6
5